官方服务：
资源简介：
This project investigated the impact of An on the development of MAFLD.
应用场景：
创建时间：
2025-09-29
相关数据集
Additional file 2 of Metabolome profiling across liver lobes and metabolic shifts of the MASLD mice
Supplementary Material 2
Figshare2025-04-16 更新60
Wilson et al Supplemental Table 3
Supplemental Table 3 for "Elongation factor 1A1 inhibition elicits changes in lipid droplet size, the bulk transcriptome, and cell type-associated gene expression in MASLD mouse liver"
Figshare2024-08-06 更新50
Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, glucose production and its absence alters liver disease progression (LIVER). Hepatocyte-derived DPP4 regulates portal GLP-1 bioactivity, glucose production and its absence alters liver disease progression (LIVER)
Elevated circulating dipeptidyl-peptidase 4 (DPP4) is a biomarker for liver disease, but its involvement in gluconeogenesis and metabolic associated fatty liver disease (MAFLD) progression remains unc
NIAID Data Ecosystem30
Comparison by number of risk factors in MAFLD.
Comparison by number of risk factors in MAFLD.
NIAID Data Ecosystem50
Table_1_Triglyceride-Rich Lipoproteins and Glycoprotein A and B Assessed by 1H-NMR in Metabolic-Associated Fatty Liver Disease.docx
High plasma triglyceride (TG) levels and chronic inflammation are important factors related to metabolic-associated fatty liver disease in patients at cardiovascular risk. Using nuclear magnetic reson
NIAID Data Ecosystem30
